[Federal Register: January 14, 2004 (Volume 69, Number 9)]
[Notices]               
[Page 2160]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr14ja04-95]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 19, 2003, and published in the Federal 
Register on September 2, 3003, (68 FR 52224), Bristol Myers Squibb 
Pharma Company, 1000 Stewart Avenue, Garden City, New York 11530, made 
application by renewal to the Drug Enforcement Administration for 
registration as a bulk manufacturer of Oxycodone (9143), a basic class 
of controlled substance listed in Schedule II.
    The firm plans to manufacture the controlled substance to make 
finished products.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Bristol Myers Squibb Pharma Company 
to manufacture the listed controlled substance is consistent with the 
public interest at this time. DEA has investigated Bristol Myers Squibb 
Pharma Company to ensure that the company's registration is consistent 
with the public interest. This investigation has included inspection 
and testing of the company's physical security systems, verification of 
the company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 823 
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office 
of Diversion Control, hereby orders that the application submitted by 
the above firm for registration as a bulk manufacturer of the basic 
class of controlled substance listed is granted.

    Dated: December 8, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-721 Filed 1-13-04; 8:45 am]

BILLING CODE 4410-09-M